Unknown

Dataset Information

0

TSG-6 released from adipose stem cells-derived small extracellular vesicle protects against spinal cord ischemia reperfusion injury by inhibiting endoplasmic reticulum stress.


ABSTRACT:

Background

Spinal cord ischemia reperfusion injury (SCIRI) is a complication of aortic aneurysm repair or spinal cord surgery that is associated with permanent neurological deficits. Mesenchymal stem cell (MSC)-derived small extracellular vesicles (sEVs) have been shown to be potential therapeutic options for improving motor functions after SCIRI. Due to their easy access and multi-directional differentiation potential, adipose-derived stem cells (ADSCs) are preferable for this application. However, the effects of ADSC-derived sEVs (ADSC-sEVs) on SCIRI have not been reported.

Results

We found that ADSC-sEVs inhibited SCIRI-induced neuronal apoptosis, degradation of tight junction proteins and suppressed endoplasmic reticulum (ER) stress. However, in the presence of the ER stress inducer, tunicamycin, its anti-apoptotic and blood-spinal cord barrier (BSCB) protective effects were significantly reversed. We found that ADSC-sEVs contain tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6) whose overexpression inhibited ER stress in vivo by modulating the PI3K/AKT pathway.

Conclusions

ADSC-sEVs inhibit neuronal apoptosis and BSCB disruption in SCIRI by transmitting TSG-6, which suppresses ER stress by modulating the PI3K/AKT pathway.

SUBMITTER: Lu X 

PROVIDER: S-EPMC9281104 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

TSG-6 released from adipose stem cells-derived small extracellular vesicle protects against spinal cord ischemia reperfusion injury by inhibiting endoplasmic reticulum stress.

Lu Xiao X   Lv Chengtang C   Zhao Yuechao Y   Wang Yufei Y   Li Yao Y   Ji Chengyue C   Wang Zhuanghui Z   Ye Wu W   Yu Shunzhi S   Bai Jianling J   Cai Weihua W  

Stem cell research & therapy 20220713 1


<h4>Background</h4>Spinal cord ischemia reperfusion injury (SCIRI) is a complication of aortic aneurysm repair or spinal cord surgery that is associated with permanent neurological deficits. Mesenchymal stem cell (MSC)-derived small extracellular vesicles (sEVs) have been shown to be potential therapeutic options for improving motor functions after SCIRI. Due to their easy access and multi-directional differentiation potential, adipose-derived stem cells (ADSCs) are preferable for this applicati  ...[more]

Similar Datasets

| S-EPMC8960015 | biostudies-literature
| S-EPMC7098915 | biostudies-literature
| S-EPMC8170662 | biostudies-literature
| S-EPMC10570331 | biostudies-literature
| S-EPMC5970094 | biostudies-literature
| S-EPMC7575949 | biostudies-literature
| S-EPMC4635566 | biostudies-literature
| S-EPMC9938143 | biostudies-literature
| S-EPMC10768662 | biostudies-literature
| S-EPMC9436815 | biostudies-literature